Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination

The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerging variants raises concerns about their capacity to evade immune protection provided by natural infection or vaccination. The receptor-binding domain (RBD) of the viral spike protein is the major target of neutral...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Luis, Pablo, Aguilar, Ruth, Pelegrin-Pérez, Judit, Ruiz-Olalla, Gemma, García-Basteiro, Alberto L., Tortajada, Marta, Moncunill, Gemma, Dobaño, Carlota, Angulo, Ana, Engel, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019072/
https://www.ncbi.nlm.nih.gov/pubmed/35464418
http://dx.doi.org/10.3389/fimmu.2022.816389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019072/
https://www.ncbi.nlm.nih.gov/pubmed/35464418
http://dx.doi.org/10.3389/fimmu.2022.816389

Ejemplares similares